Matthias Weckesser

6.2k total citations
148 papers, 4.0k citations indexed

About

Matthias Weckesser is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Matthias Weckesser has authored 148 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Radiology, Nuclear Medicine and Imaging, 59 papers in Pulmonary and Respiratory Medicine and 26 papers in Surgery. Recurrent topics in Matthias Weckesser's work include Medical Imaging Techniques and Applications (42 papers), Radiopharmaceutical Chemistry and Applications (34 papers) and Glioma Diagnosis and Treatment (25 papers). Matthias Weckesser is often cited by papers focused on Medical Imaging Techniques and Applications (42 papers), Radiopharmaceutical Chemistry and Applications (34 papers) and Glioma Diagnosis and Treatment (25 papers). Matthias Weckesser collaborates with scholars based in Germany, United States and Switzerland. Matthias Weckesser's co-authors include Kambiz Rahbar, Otmar Schober, Michael Schäfers, Martin Bögemann, Lars Stegger, Robert Seifert, Karl‐Josef Langen, Walter Heindel, Katharina Kessel and Christiane Franzius and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and NeuroImage.

In The Last Decade

Matthias Weckesser

143 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Weckesser Germany 33 2.0k 1.6k 624 613 591 148 4.0k
Kazuo Kubota Japan 40 1.6k 0.8× 1.4k 0.9× 565 0.9× 529 0.9× 731 1.2× 186 4.5k
Christiaan Schiepers United States 36 3.1k 1.6× 1.5k 1.0× 930 1.5× 616 1.0× 501 0.8× 72 4.7k
Frederic H. Fahey United States 31 1.9k 1.0× 941 0.6× 550 0.9× 550 0.9× 452 0.8× 146 4.5k
Roland Hustinx Belgium 38 2.8k 1.4× 1.5k 0.9× 897 1.4× 323 0.5× 519 0.9× 150 5.6k
June-Key Chung South Korea 37 2.1k 1.1× 1.1k 0.7× 744 1.2× 230 0.4× 591 1.0× 152 4.4k
Tohru Shiga Japan 32 1.7k 0.9× 905 0.6× 256 0.4× 450 0.7× 311 0.5× 181 3.7k
David Bonekamp Germany 35 3.2k 1.6× 2.3k 1.5× 401 0.6× 875 1.4× 282 0.5× 131 5.2k
Emmanuel Itti France 37 2.1k 1.1× 1.2k 0.7× 711 1.1× 276 0.5× 290 0.5× 149 4.4k
Masayuki Sasaki Japan 34 1.6k 0.8× 810 0.5× 532 0.9× 193 0.3× 352 0.6× 165 3.7k
Zhaohui Zhu China 33 1.2k 0.6× 616 0.4× 1.0k 1.6× 275 0.4× 519 0.9× 149 3.3k

Countries citing papers authored by Matthias Weckesser

Since Specialization
Citations

This map shows the geographic impact of Matthias Weckesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Weckesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Weckesser more than expected).

Fields of papers citing papers by Matthias Weckesser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Weckesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Weckesser. The network helps show where Matthias Weckesser may publish in the future.

Co-authorship network of co-authors of Matthias Weckesser

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Weckesser. A scholar is included among the top collaborators of Matthias Weckesser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Weckesser. Matthias Weckesser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schäfers, Michael, Martin Bögemann, Philipp Schindler, et al.. (2024). Determination of the optimal imaging protocol for [18F]PSMA-PET-CT for the detection of bone metastases in prostate cancer patients. Nuklearmedizin - NuclearMedicine. 63(5). 287–293. 1 indexed citations
2.
Müther, Michael, Wolfgang Roll, Benjamin Brokinkel, et al.. (2020). Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma. Nuklearmedizin - NuclearMedicine. 59(5). 348–355. 14 indexed citations
3.
Seifert, Robert, Katharina Kessel, Katrin Schlack, et al.. (2020). Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis. European Journal of Nuclear Medicine and Molecular Imaging. 47(9). 2106–2112. 38 indexed citations
4.
Grauer, Oliver, Mohammed Hammad Jaber, Katharina Heß, et al.. (2018). Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients. Journal of Neuro-Oncology. 141(1). 83–94. 131 indexed citations
5.
Rahbar, Kambiz, Matthias Weckesser, Hojjat Ahmadzadehfar, et al.. (2018). Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion. European Journal of Nuclear Medicine and Molecular Imaging. 45(6). 1076–1077. 67 indexed citations
6.
Avramović, Nemanja, Angelo M. Dell’Aquila, Matthias Weckesser, et al.. (2017). Metabolic volume performs better than SUVmax in the detection of left ventricular assist device driveline infection. European Journal of Nuclear Medicine and Molecular Imaging. 44(11). 1870–1877. 19 indexed citations
7.
Vrachimis, Alexis, Lars Stegger, Christian Wenning, et al.. (2016). [68Ga]DOTATATE PET/MRI and [18F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. 43(10). 1765–1772. 10 indexed citations
8.
Hansen, Torsten, et al.. (2016). Ungewöhnliche Manifestation eines Prostatakarzinoms. Der Urologe. 56(1). 50–53. 2 indexed citations
9.
Rahbar, Kambiz, Axel Bode, Matthias Weckesser, et al.. (2016). Radioligand Therapy with Lu-177-PSMA-617 may improve survival in Patients with Metastatic Prostate Cancer. 57. 142–142. 1 indexed citations
10.
Bettenworth, Dominik, Stefan Reuter, Sven Hermann, et al.. (2013). Translational 18F-FDG PET/CT Imaging to Monitor Lesion Activity in Intestinal Inflammation. Journal of Nuclear Medicine. 54(5). 748–755. 49 indexed citations
11.
Beyer, Florian, Boris Buerke, Joachim Gerß, et al.. (2010). Beurteilung einer Lymphknoten-Metastasierung beim NSCLC – 3D-Parameter ergänzen die PET-CT nicht. Nuklearmedizin - NuclearMedicine. 49(1). 41–48. 5 indexed citations
12.
Vrachimis, Alexis, Uta Dirksen, Johannes Weßling, et al.. (2010). PET-Nachsorge von Patienten mit Ewing-Sarkomen am Körperstamm: Müssen die Unterschenkel berücksichtigt werden?. Nuklearmedizin - NuclearMedicine. 49(5). 183–186. 3 indexed citations
13.
Stegger, Lars, Kai Uwe Juergens, Sabine Kliesch, Dag Wormanns, & Matthias Weckesser. (2006). Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT. European Radiology. 17(7). 1784–1786. 29 indexed citations
14.
Löffler, Markus, Matthias Weckesser, Christiane Franzius, Otmar Schober, & K.‐P. Zimmer. (2006). High Diagnostic Value of 18F–FDG–PET in Pediatric Patients with Chronic Inflammatory Bowel Disease. Annals of the New York Academy of Sciences. 1072(1). 379–385. 86 indexed citations
15.
Juergens, Kai Uwe, Matthias Weckesser, Lars Stegger, et al.. (2006). Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?. European Radiology. 16(5). 1131–1137. 37 indexed citations
16.
Weckesser, Matthias, Karl‐Josef Langen, Christian Rickert, et al.. (2005). O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. European Journal of Nuclear Medicine and Molecular Imaging. 32(4). 422–429. 153 indexed citations
17.
Weckesser, Matthias & Otmar Schober. (2005). Is whole-body FDG-PET valuable for health screening?. European Journal of Nuclear Medicine and Molecular Imaging. 32(3). 342–343. 16 indexed citations
18.
Weckesser, Matthias, Peter Matheja, D Schmidt, H.H. Coenen, & Karl‐Josef Langen. (2000). The role of L-3-I-123-I-123-Iod-α-methyl tyrosine-SPECT in cerebral gliomas. 39(8). 233–240. 2 indexed citations
19.
Weckesser, Matthias, Peter Matheja, Christian Rickert, et al.. (2000). Evaluation of the Extension of Cerebral Gliomas by Scintigraphy. Strahlentherapie und Onkologie. 176(4). 180–185. 20 indexed citations
20.
Weckesser, Matthias, et al.. (1998). [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].. PubMed. 37(4). 156–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026